positive collaboration but will take a long time to produce anything meaningful and there are various NS5B inhibitors either on the market or in development. ATC is the value driver at the minute.
- Forums
- ASX - By Stock
- AVX
- Ann: CSIRO invests in Avexa's HCV program
Ann: CSIRO invests in Avexa's HCV program , page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online